Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anti-Cancer Drugs|December 7, 2010
Current chemotherapies for recurrent/metastatic head and neck cancerYann Molin, Jérôme Fayette
Investigational New Drugs|August 15, 2014
Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumorsMélodie Carbonnaux, Yann Molin, Pierre-Jean Souquet, et al.
Drug Design, Development and Therapy|December 10, 2015
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinomaJérôme Fayette, Yann Molin, Emilie Lavergne, et al.
Nature|December 14, 2011
DCC constrains tumour progression via its dependence receptor activityMarie Castets, Laura Broutier, Yann Molin, et al.
Cancer Medicine|November 17, 2022
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohortSylvain Manfredi, Marie Dior, Olivier Bouche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2021
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II StudyJean Marc Phelip, Jérôme Desrame, Julien Edeline, et al.
Cancer Medicine|May 6, 2019
PALLIA-10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (PREPA-10)Yann Molin, Caroline Gallay, Julien Gautier, et al.
Breast (Edinburgh, Scotland)|November 28, 2025
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03Olivier Trédan, Delphine Loirat, Sylvie Chabaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic AdenocarcinomaPascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, et al.
Pageof 1